21403896|t|VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease.
21403896|a|Dopamine is transported into synaptic vesicles by the vesicular monoamine transporter (VMAT2; SLC18A2). Disruption of dopamine storage has been hypothesized to damage the dopamine neurons that are lost in Parkinson's disease. By disrupting vesicular storage of dopamine and other monoamines, we have created a progressive mouse model of PD that exhibits catecholamine neuron loss in the substantia nigra pars compacta and locus coeruleus and motor and nonmotor symptoms. With a 95% reduction in VMAT2 expression, VMAT2-deficient animals have decreased motor function, progressive deficits in olfactory discrimination, shorter latency to behavioral signs of sleep, delayed gastric emptying, anxiety-like behaviors at younger ages, and a progressive depressive-like phenotype. Pathologically, the VMAT2-deficient mice display progressive neurodegeneration in the substantia nigra (SNpc), locus coeruleus (LC), and dorsal raphe (DR) coupled with alpha-synuclein accumulation. Taken together, these studies demonstrate that reduced vesicular storage of monoamines and the resulting disruption of the cytosolic environment may play a role in the pathogenesis of parkinsonian symptoms and neurodegeneration. The multisystem nature of the VMAT2-deficient mice may be useful in developing therapeutic strategies that go beyond the dopamine system.
21403896	0	5	VMAT2	Gene	214084
21403896	16	20	Mice	Species	10090
21403896	97	116	Parkinson's Disease	Disease	MESH:D010300
21403896	118	126	Dopamine	Chemical	MESH:D004298
21403896	205	210	VMAT2	Gene	214084
21403896	212	219	SLC18A2	Gene	214084
21403896	236	244	dopamine	Chemical	MESH:D004298
21403896	289	297	dopamine	Chemical	MESH:D004298
21403896	323	342	Parkinson's disease	Disease	MESH:D010300
21403896	379	387	dopamine	Chemical	MESH:D004298
21403896	398	408	monoamines	Chemical	-
21403896	440	445	mouse	Species	10090
21403896	455	457	PD	Disease	MESH:D010300
21403896	472	497	catecholamine neuron loss	Disease	MESH:C536334
21403896	613	618	VMAT2	Gene	214084
21403896	631	636	VMAT2	Gene	214084
21403896	808	815	anxiety	Disease	MESH:D001007
21403896	866	876	depressive	Disease	MESH:D003866
21403896	913	918	VMAT2	Gene	214084
21403896	929	933	mice	Species	10090
21403896	954	971	neurodegeneration	Disease	MESH:D019636
21403896	1061	1076	alpha-synuclein	Gene	20617
21403896	1167	1177	monoamines	Chemical	-
21403896	1275	1296	parkinsonian symptoms	Disease	MESH:D010302
21403896	1301	1318	neurodegeneration	Disease	MESH:D019636
21403896	1350	1355	VMAT2	Gene	214084
21403896	1366	1370	mice	Species	10090
21403896	1441	1449	dopamine	Chemical	MESH:D004298
21403896	Association	MESH:D003866	214084
21403896	Association	MESH:D019636	214084
21403896	Association	MESH:D004298	MESH:C536334
21403896	Positive_Correlation	MESH:D019636	20617
21403896	Association	MESH:D010300	214084
21403896	Association	MESH:D004298	214084
21403896	Association	20617	214084
21403896	Association	MESH:D001007	214084
21403896	Association	MESH:D004298	MESH:D010300

